Immune checkpoint inhibitor resistance in dMMR high-grade intraepithelial neoplasia with lynch syndrome-associated colon cancer: a case report
Open Access
- 23 April 2026
- journal article
- case report
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Abstract
Immune checkpoint inhibitors demonstrate high efficacy in MSI-H/dMMR colorectal cancer, yet a subset of patients develops resistance. This case reports inKeywords
Funding Information
- the Natural Science Foundation of Jiangxi Province (20242BAB26146)
- National Natural Science Foundation of China (82160464)
- the “Double Thousand” project for training high-level talents of scientific and technological innovation in Jiangxi Province (jxsq2023201038)
This publication has 51 references indexed in Scilit:
- Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancerCancer Immunology, Immunotherapy, 2021
- Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinomaCell, 2021
- NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysisTranslational Oncology, 2021
- Tumor microenvironment as a therapeutic target in cancerPharmacology & Therapeutics, 2020
- Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid TumorsCancer Cell, 2020
- Macrophages and Metabolism in the Tumor MicroenvironmentCell Metabolism, 2019
- Prognostic impact of tumour‐infiltrating B cells and plasma cells in colorectal cancerInternational Journal of Cancer, 2016
- Tumor-Associated Macrophages: From Mechanisms to TherapyImmunity, 2014
- The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinomaCancer, 1997